If you or someone you love is facing a diffuse large B-cell lymphoma (DLBCL) diagnosis, and the lymphoma has either relapsed or has not responded to initial treatment, read on to learn about new treatment options that can help.

In December 2020, CSC hosted a 3-day virtual summit on the topic of precision medicine. The summit was an action-oriented event focused on eliciting feedback from patients regarding CSC precision medicine education materials and educating the cancer community on the promise of precision medicine and the barriers and gaps that exist in ensuring access for all.

When it comes to treatment decisions, many cancer patients are worried about more than just treating the cancer. CSC’s Research and Training Institute asked patients to share their perspectives on this in two different research studies, and the findings highlighted that when it comes to deciding which cancer treatment to pursue, there’s a lot to consider.

The Cancer Support Community is excited to announce the launch of its new Biomarker Testing Tool for lung cancer. This groundbreaking streamlined platform empowers lung cancer patients and their loved ones to be informed and active participants in the treatment decision-making process.